Last update :
17/04/2024
Antihistamine (H2)   Famotidine  
Injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anfamox Australia
Facid India
Famodil Italy
Famotidina Chile
Famotidine Canada, United States of America
Femidin India
Gaster Japan
Gastrium Chile
Kinotal Venezuela
Motiax Italy
Nevofam - L Turkey
Pepcidine Australia, Luxembourg, Netherlands
Pepdine Morocco
Quamatel Hungary, Poland, Romania
Ulcusan Austria
Stability in solutions   Injection   Stability in solutions : Famotidine     
Container Solvent Concentration Temperature Storage Duration of stability References
Polyvinyl chloride Water for Injection 2 mg/ml 4°C Protect from light
14 Day
690
Level of evidence A

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml -20°C Protect from light
28 Day
553
Level of evidence B

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 22°C With or without light
15 Day
215
Level of evidence A

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 25°C Not specified
15 Day
693
Level of evidence D

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 4°C Protect from light
14 Day
553
Level of evidence B

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 4°C Protect from light
63 Day
693
Level of evidence D

Polyvinyl chloride NaCl 0,9% or Glucose 5% 2 mg/ml 4°C Protect from light
14 Day
690
Level of evidence A

Polypropylen Syringe Water for Injection 2 mg/ml -20°C Protect from light
56 Day
77
Level of evidence B

Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,2 mg/ml 22°C With or without light
15 Day
215
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 2 mg/ml -20°C Protect from light
56 Day
77
Level of evidence B

Polypropylen Syringe Glucose 5% 2 mg/ml -20°C Protect from light
21 Day
77
Level of evidence B


  Mentions Légales